Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes
Research output: Contribution to journal › Journal article › Research › peer-review
Endothelial progenitor cells (EPC) augment vascular repair and neovascularisation. Patients with type 2 diabetes have reduced EPC and increased risk of cardiovascular disease (CVD), which is reduced by multifactorial intervention. Our aim, therefore, was to evaluate in type 2 diabetic patients whether the numbers of EPC derived from peripheral blood mononuclear cells is influenced by a multifactorial treatment strategy.
| Original language | English |
|---|---|
| Journal | Diabetologica |
| Volume | 53 |
| Issue number | 10 |
| Pages (from-to) | 2129-33 |
| Number of pages | 5 |
| ISSN | 1432-0428 |
| DOIs | |
| Publication status | Published - 1 Oct 2010 |
- Angiotensin Receptor Antagonists, Aspirin, Cell Count, Cells, Cultured, Diabetes Mellitus, Type 2, Diet, Reducing, Endothelial Cells, Exercise Therapy, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Leukocytes, Mononuclear, Life Style, Male, Metformin, Stem Cells, Treatment Outcome
Research areas
ID: 33901146